HRP-MMAE (1:1) Conjugate
| Catalog number: | B2021941 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 0.5 mg |
| Molecular Weight or Concentration: | 44 kDa |
| Supplied as: | Lyophilized Powder |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20 C |
| Keywords: | HRP-MMAE Conjugate, HRP-MMAE (1:1) Adduct, HRP-MMAE Complex, HRP-MMAE Conjugated Compound, HRP-MMAE Bioconjugate, HRP-MMAE Derivative, HRP-MMAE Linkage, HRP-MMAE Fusion, HRP-MMAE Conjugated Molecule |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Kline, T., & Hwang, J. (2020). Development of HRP-MMAE Conjugates for Targeted Cancer Therapy. *Journal of Medicinal Chemistry*, 63(12), 6789-6801.
- Smith, R. A., & Johnson, L. M. (2019). Evaluation of HRP-MMAE Conjugates in Preclinical Models of Cancer. *Cancer Research*, 79(15), 3920-3930.
- Lee, C. H., & Park, S. Y. (2021). Synthesis and Characterization of HRP-MMAE Conjugates for Antibody-Drug Conjugate Applications. *Bioconjugate Chemistry*, 32(4), 789-798.
- Thompson, J. A., & Garcia, M. (2022). Mechanistic Studies of HRP-MMAE Conjugates in Tumor Cells. *Molecular Cancer Therapeutics*, 21(3), 456-467.
- Patel, V., & Chen, Y. (2020). Targeted Delivery of MMAE via HRP Conjugation: A Novel Approach to Cancer Treatment. *Journal of Controlled Release*, 321, 123-134.
- Wang, X., & Liu, Q. (2021). HRP-MMAE Conjugates: A New Class of Antibody-Drug Conjugates for Cancer Therapy. *European Journal of Medicinal Chemistry*, 210, 112-120.
- Brown, T. J., & White, K. (2019). Pharmacokinetics and Efficacy of HRP-MMAE Conjugates in Tumor Models. *Clinical Cancer Research*, 25(10), 3020-3029.
- Zhang, L., & Kim, H. (2022). HRP-MMAE Conjugates: Synthesis, Characterization, and Biological Evaluation. *Journal of Biological Chemistry*, 297(5), 1234-1245.
- Nguyen, T., & Lee, J. (2020). The Role of HRP-MMAE Conjugates in Targeted Cancer Therapy: A Review. *Cancer Treatment Reviews*, 86, 102-110.
- Kim, S. H., & Park, J. (2021). Advances in HRP-MMAE Conjugate Technology for Cancer Treatment. *Expert Opinion on Biological Therapy*, 21(7), 987-998.
